BusinessAdamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical PracticeBy Nasdaq OMXFeb 8, 2018, 2:01 PM UTC
BusinessZero DBS Electrode Infections Reported When Utilizing the ClearPoint® NeuroNavigation System in an MRI SuiteBy Nasdaq OMXApr 20, 2016, 1:00 PM UTC
